Chicago—With lung cancer claiming the lives of more men and women than colon, breast, and prostate cancers combined, the need for agents to prevent this malignancy has never been more urgent. Although efforts have been unsuccessful to date, preliminary research reported here at the recent Annual Meeting of the American Society of Clinical Oncology suggests that drugs that inhibit the cyclooxygenase 2 (COX-2) enzyme may have potential as chemoprevention agents.
Hampton T. New Studies Target Lung Cancer Prevention, Imaging, and Treatment. JAMA. 2008;300(3):267–268. doi:10.1001/jama.2008.49